Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pasithea Therapeutics (KTTA) Gross Margin (2022)

Pasithea Therapeutics (KTTA) has disclosed Gross Margin for 1 consecutive years, with 100.54% as the latest value for Q4 2022.

  • Quarterly Gross Margin changed N/A to 100.54% in Q4 2022 from the year-ago period, while the trailing twelve-month figure was 76.74% through Dec 2022, changed N/A year-over-year, with the annual reading at 76.74% for FY2022, 9143.0% up from the prior year.
  • Gross Margin hit 100.54% in Q4 2022 for Pasithea Therapeutics, up from 60.45% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 100.54% in Q4 2022 to a low of 11.19% in Q2 2022.